FDA committee moves Pfizer-BioNTech COVID-19 vaccine closer to use for children ages 5-11

FDA committee moves Pfizer-BioNTech COVID-19 vaccine closer to use for children ages 5-11

Baca Juga

In children ages 5-11, the Pfizer-BioNTech vaccine was more than 90% protective against contracting symptomatic COVID-19, according to company data.

     


from USATODAY - News Top Stories https://ift.tt/3mhEckJ
via IFTTT

Related Posts

0 Response to "FDA committee moves Pfizer-BioNTech COVID-19 vaccine closer to use for children ages 5-11"

Post a Comment